Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired and normal fasting glucose

被引：0
|
作者：
Maki, Kevin C. [1 ]
McKenney, James M. [2 ]
Farmer, Mildred V. [3 ]
Reeves, Matthew S. [1 ]
Dicklin, Mary R. [1 ]
机构：
[1] Provident Clin Res, Bloomington, IN USA
[2] Natl Clin Res, Richmond, VA USA
[3] Meridien Res, St Petersburg, FL USA
来源：
FASEB JOURNAL | 2009年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
351.1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] In Vivo Insulin Sensitivity and Secretion in Obese Youth What are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
    Bacha, Fida
    Gungor, Neslihan
    Lee, SoJung
    Arslanian, Silva A.
    DIABETES CARE, 2009, 32 (01) : 100 - 105
  • [32] Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes
    Satin, Leslie S.
    Butler, Peter C.
    Ha, Joon
    Sherman, Arthur S.
    MOLECULAR ASPECTS OF MEDICINE, 2015, 42 : 61 - 77
  • [33] Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose
    Mustafa Kanat
    Luke Norton
    Diedre Winnier
    Chris Jenkinson
    Ralph A. DeFronzo
    Muhammad A. Abdul-Ghani
    Acta Diabetologica, 2011, 48
  • [34] Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose
    Kanat, Mustafa
    Norton, Luke
    Winnier, Diedre
    Jenkinson, Chris
    DeFronzo, Ralph A.
    Abdul-Ghani, Muhammad A.
    ACTA DIABETOLOGICA, 2011, 48 (03) : 209 - 217
  • [35] Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
    Toenjes, Anke
    Fasshauer, Mathias
    Kratzsch, Juergen
    Stumvoll, Michael
    Blueher, Matthias
    PLOS ONE, 2010, 5 (11):
  • [36] Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects
    Salgin, B.
    Marcovecchio, M. L.
    Humphreys, S. M.
    Hill, N.
    Chassin, L. J.
    Lunn, D. J.
    Hovorka, R.
    Dunger, D. B.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (03): : E454 - E461
  • [37] A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T. C.
    Schwartz, S.
    Rosenberg, M. A.
    Jarlwala, N.
    Becker, R. H. A.
    Johnston, P. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (05) : 282 - 288
  • [38] The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity
    Gerich, JE
    ENDOCRINE REVIEWS, 1998, 19 (04) : 491 - 503
  • [39] Evaluatioin of the safety, efficacy and tolerability of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T
    Schwartz, S
    Rosenberg, M
    Johnston, P
    Jariwala, N
    Shukla, U
    Becker, R
    Saoud, J
    DIABETES, 2003, 52 : A451 - A452
  • [40] Effects of rosglitazone on plasma adiponectin, insulin sensitivity and insulin secretion in high risk African Americans with impaired glucose tolerance test and type 2 diabetes
    Osel, K
    Gaillard, T
    Schuster, D
    Kaplow, J
    Bullock, M
    DIABETES, 2004, 53 : A159 - A159
12345